Efficacy and safety of capecitabine therapy in patients with Biliary tract cancer: A systematic review and meta-analysis
Journal of Oncology Pharmacy Practice
Published online on September 13, 2025
Abstract
Journal of Oncology Pharmacy Practice, Ahead of Print.
BackgroundCapecitabine, an oral fluoropyrimidine prodrug, has demonstrated promising activity in Biliary tract cancers (BTC), but its role in combination chemotherapy is still debated.ObjectiveTo evaluate the efficacy and safety of capecitabine, both ...
BackgroundCapecitabine, an oral fluoropyrimidine prodrug, has demonstrated promising activity in Biliary tract cancers (BTC), but its role in combination chemotherapy is still debated.ObjectiveTo evaluate the efficacy and safety of capecitabine, both ...